medigraphic.com
ISSN 2221-2434 (Electronic)

2019, Number 4

<< Back Next >>

Finlay 2019; 9 (4)

Use of cystatin C biomarker in patients with possible renal failure

Benavides CA, Rodríguez JY, González BD, Martinez SIL, Hernandez PI, Vilaboy PBR

Language: Spanish
References: 31
Page: 306-313
PDF size: 135.82 Kb.


ABSTRACT

Renal injury is a frequent complication in hospitalized and outpatients and its incidence has increased in recent years, either as a primary disease or as a secondary diagnosis. Early detection of kidney disease in its milder degree would be beneficial to begin treatment for better results. This literature review, based on the analysis of about 30 scientific articles, describes the feasibility of using cystatin C as a renal biomarker; it also refers to the advantages and limitations that its use reports within the clinical bioanalysis; and finally the importance of the future use of cystatin C as an analytical biomarker in different laboratories of the health system in Cienfuegos. This work provides relevant information about health personnel´s updating and training in medical conditions which may be detected at the molecular and cellular level.


REFERENCES

  1. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb CH, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults. Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20

  2. Oleksyk TK, Nelson GW, An P, Kopp JB, Winkler CA. Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa. PloS One. 2010;5(7):114-74

  3. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC. Guidelines for the management of arterial hypertension: The task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281-357

  4. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation. 2014;129(3):28-292

  5. Stevens PE, Levin A. Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825-30

  6. Espinosa A, Amezcua AL, Ruiz PC, Rodríguez F, Díaz E. Nuevos marcadores de lesión renal aguda en el enfermo grave. Med Int Mex [revista en Internet]. 2013 [citado 14 Mar 2018];29(5):[aprox. 5p]. Disponible en: https://www.medigraphic.com/pdfs/medintmex/m im-2013/mim135j.pdf

  7. Herrick JB. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Yale J BiolMed. 2001;74(3):179-84

  8. Serjeant GR. Renal Manifestation in Sickle cell Disease. 2nd. ed. Oxford: University Press; 1992

  9. Muñiz A, Puig A, Cabrera M, Fernández J, Martínez G. Marcadores genéticos en pacientes con anemia drepanocítica de la provincia de Cienfuegos: Haplotipos del bloque b y a -Talasemia. Rev Cubana Hemato lnmunol Hemoter [revista en Internet]. 2000 [citado 18 Ene 2014];16(2):[aprox. 4p]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S0864-02892000000200010&nrm=iso

  10. Svarch E. Fisiopatología de la drepanocitosis. Rev Cubana Hematol Inmunol Hemoter [revista en Internet]. 2009 [citado 18 Ene 2014];25(1):[aprox. 12p]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S0864-02892009000100003&lng=es&nrm=i so&tlng=es

  11. Pham PT, Pham PC, Wilkinson AH, Lew SQ. Renal abnormalities in sickle cell disease. Kidney Int. 2000;57(1):1-8

  12. Ataga KI, Orringer EP. Renal abnormalities in sickle cell disease. Am J Hematol. 2000;63(4):205-11

  13. Sharpe CC, Thein SL. How I treat renal complications in sickle cell disease. Blood. 2014;123(24):3720-6

  14. Pereira R, Ferreira A, Bispo SM, Velasco PR, Leal AA. Glomerular filtration rate is altered in children with sickle cell disease: a comparison between Hb SS and Hb SC. Rev Bras Hematol Hemoter. 2013;35(5):349-51

  15. Lombi F, Muryan A, Canzonieri R, Trimarchi H. Biomarcadores en la lesión renal aguda: ¿paradigma o evidencia?. Nefrología [revista en Internet]. 2016 [citado 14 Mar 2018];36(4):[aprox. 7p]. Disponible en: http://www.revistanefrologia.com/es-biomarcador es-lesion-renal-aguda--articulo-S0211699516300 273

  16. Fernández M, Coll E, Ventura S, Bermudo C, Cárdenas MC, Cortes M, et al. Cistatina c en la evaluación de la función renal. Rev Lab Clin [revista en Internet]. 2011 [citado 14 Feb 2018];4(1):[aprox. 6p]. Disponible en: http://www.elsevier.es/es-revista-revista-del-labo ratorio-clinico-282-pdf

  17. Castellanos Y, Fong JA, Vázquez JM, Oliva J. Marcadores de daño renal en pacientes con factores de riesgo de enfermedad renal crónica. MEDISAN [revista en Internet]. 2018 [citado 22 Feb 2018];22(2):[aprox. 18p]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S1029-30192018000200004

  18. Barbarash OL, Bykova IS, Kashtalap V, Zykov MV, Hryachkova ON, Kalaeva VV, et al. Serum neutrophil gelatinase-associated lipocalin has an advantage over serum cystatin C and glomerular filtration rate in prediction of adverse cardiovascular outcome in patients with ST-segment elevation myocardial infarction. BMC Cardiovasc Disord. 2017;17(1):81

  19. Alonso A, Melgosa M. La Cistatina c para la valoración de la función renal en pediatría. An Pediatr Contin. 2005;3(4):239-43

  20. Salazar M, Parra I, Klunder M, Martínez M, Vera H, Benavides MA, et al. Cistatina C como prueba de rutina para evaluar la función renal en pacientes pediátricos. Acta Bioquim Clin Latinam [revista en Internet]. 2015 [citado 17 Feb 2018];49(2):[aprox. 15p]. Disponible en: http://www.researchgate.net/publication/282764 001_Cistatina_C_como_prueba_de_rutina_para_ev aluar_la_funcion_renal_en_pacientes_pediatricos/ download

  21. Domingueti CP, Fóscolo RB, Simões AC,Dusse LM, Reis JS, CarvalhoMd, et al. Evaluation of creatinine-based and cystatin C-based equations for estimation of glomerular filtration rate type 1 diabetic patients. Arch Endocrinol Metab. 2016;60(2):108-16

  22. López K, Ricard MP. Afectación renal en la enfermedad falciforme. Nefrología [revista en Internet]. 2011 [citado Mar 22];31(5):[aprox. 20p]. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext &pid=S0211-69952011000500012

  23. Martínez A, Górriz JL, Bover J, Segura J, Cebollada J, Escalada J, et al. Documento de consenso para la detección y manejo de la enfermedad renal crónica. Nefrología [revista en Internet]. 2014 [citado 15 Mar 2018];34(2):[aprox. 18p]. Disponible en: http://www.revistanefrologia.com/es-documentoconsenso-deteccion-manejo-enfermedad-articuloX0211699514053919

  24. Burnett AL, Bivalacqua TJ. Priapism: current principles and practice. Urol Clin North Am. 2007;34(4):631-42

  25. Thompson J, Reid M, Hambleton I, Serjeant GR. Albuminuria and renal function in homozygous sickle cell disease: observations from a cohort study. Arch Intern Med. 2007;167(7):701-8

  26. Audard V, Homs S, Habibi A, Galacteros F, Bartolucci P, Godeau B, et al. Acute Kidney injury in sickle patients with painful crisis or acute chest syndrome and its relation to pulmonary hypertension. Nephrol Dial Transplant. 2010;25(8):2524-9

  27. Balci A, Karazincir S, Sangün O, Gali E, Daplan T, Cingiz C, et al. Prevalence of abdominal ultrasonographic abnormalities in patients with sickle cell disease. Diagn Interv Radiol. 2008;14(3):133-7

  28. Svarch E, Marcheco B, Machín S, Menéndez A, Nordet I, Arencibia A, et al. La drepanocitosis en Cuba. Estudio en niños. Rev Cubana Hematol Inmunol Hemoter [revista en Internet]. 2011 [citado 18 Nov 2018];27(1):[aprox. 18p]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext& pid=S0864-02892011000100005

  29. Kotila TR, Shokunbi WA. Survival advantage in female patients with sickle cell anemia. East Afr Med J. 2001;78(7):373-5

  30. López A, Sartori J, Yanes LL, Iliescu R, Reckelhoff JF. Sex differences in control of blood pressure: role of oxidative stress in hypertension in females. Am J Physiol Heart Circ Physiol. 2008;295(2):466-74

  31. Guasch A, Navarrete J, Nass K, Zayas CF. Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlations of progressive renal failure. J Am Soc Nephrol. 2006;17(8):2228-35.




2020     |     www.medigraphic.com